Myasthenia gravis affects about 30 out of every 100,000 people in Canada, according to the Myasthenia Gravis Society of ...

Approximately 70 to 300 million individuals worldwide are living with myasthenia gravis, an antibody-mediated autoimmune disorder that adversely affects neuromuscular junction function. “Research has ...

Richard J. Nowak, MD, MS, Yale School of Medicine, explains what some early myasthenia gravis symptoms are and their impact on research efforts. Revisit part 1 of this interview, where Nowak discusses ...

UCB S.A. UCBJY UCBJF on Wednesday presented new data at the International Congress on Neuromuscular Diseases 2026 showing ...

New York, USA, June 02, 2026 (GLOBE NEWSWIRE) -- Myasthenia Gravis Clinical Trial Pipeline Expands as 25+ Companies Race to Redefine Myasthenia Gravis Treatment Landscape | DelveInsight DelveInsight's ...

Biologics License Application acceptance supported by results from the Phase 3 Vivacity-MG3 study Results demonstrate sustained disease control over 24 weeks in a broad population of antibody positive ...

Myasthenia gravis is a chronic autoimmune disorder that disrupts nerve-to-muscle signaling, causing weakness. Modern treatments help many people live typical life spans and enter remission.

Myasthenia gravis (MG) medications can improve symptoms and quality of life, even though MG is chronic and has no current cure. Pyridostigmine bromide (Mestinon), a cholinesterase inhibitor, is often ...

Add Yahoo as a preferred source to see more of our stories on Google. Despite being so rare, "improved awareness and diagnostic techniques have led to more frequent diagnoses and better care," says ...

CNW/ - UCB Canada Inc. announced today the company has entered into Product Listing Agreements with British Columbia, Quebec, Alberta, Saskatchewan, ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Nicholas J.

Tennis legend Monica Seles is opening up about her journey with myasthenia gravis, a neuromuscular autoimmune disease she was diagnosed with three years ago. In a recent interview with The Associated ...